Hemocept Inc.
Clinical trials sponsored by Hemocept Inc., explained in plain language.
-
New device aims to improve safety in heart valve replacement
Knowledge-focused Recruiting nowThis pilot study is testing a new device called HemoCept that measures blood volume and heart efficiency during trans-aortic valve replacement (TAVR) surgery for aortic stenosis. The study will enroll 20 adults aged 18-80 who need TAVR. Researchers want to see if the device's rea…
Sponsor: HemoCept Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
New heart monitor device tested in small study
Knowledge-focused Recruiting nowThis study is testing a new device called HemoCept during a standard heart procedure called right heart catheterization. The goal is to see if the device can accurately measure pressure in the heart's blood vessels. About 50 adults with conditions like pulmonary hypertension or h…
Sponsor: HemoCept Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC